SCHEMBL25754831

SCHEMBL25754831

CC(C)c1ccc(N)cc1S(=O)(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
POLB P06746 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
PRMT1 Q99873 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
IDH1 O75874 4/20 0.47
GAA P10253 2/20 0.46
CES1 P23141 1/20 0.45
PGR P06401 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC1 Q13547 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CYP26A1 O43174 1/20 0.42
MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15647028 0.81 IDH1 (0.66) MAPTTDP1POLBNPSR1IDH1
SCHEMBL18382564 0.81 HDAC1 (0.53) MAPTPRMT1MEN1KMT2AIDH1
SCHEMBL23846522 0.80 POLB (0.60) MAPTTDP1POLBNPSR1PRMT1
SCHEMBL25759085 0.79 IDH1 (0.53) MAPTPOLBNPSR1MEN1KMT2A
SCHEMBL25754837 0.79 MAPT (0.58) MAPTTDP1POLBNPSR1PRMT1
SCHEMBL25754817 0.78 NPSR1 (0.62) MAPTTDP1POLBNPSR1MEN1
SCHEMBL20462105 0.76 HDAC1 (0.49) MAPTMEN1KMT2AIDH1PGR
SCHEMBL25759570 0.74 L3MBTL1 (0.39) MAPTTDP1POLBNPSR1MEN1
SCHEMBL15651278 0.72 KDM4E (0.41) MAPTTDP1POLBMEN1KMT2A
SCHEMBL29118839 0.72 ALDH1A1 (0.67) MAPTTDP1PRMT1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 MAPT 89/4885TDP1 26/4885POLB 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.